美国 - 英文 - NLM (National Library of Medicine)

genmab us, inc. - epcoritamab (unii: d6omy2l0wa) (epcoritamab - unii:d6omy2l0wa) - epkinly is indicated for the treatment of adult patients with relapsed or refractory diffuse large b-cell lymphoma (dlbcl), not otherwise specified, including dlbcl arising from indolent lymphoma, and high-grade b-cell lymphoma after two or more lines of systemic therapy. this indication is approved under accelerated approval based on response rate and durability of response [see clinical studies (14)]. continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial(s). none. risk summary based on the mechanism of action, epkinly may cause fetal harm when administered to a pregnant woman [see clinical pharmacology (12.1)] . there are no available data on the use of epkinly in pregnant women to evaluate for a drug-associated risk. no animal reproductive or developmental toxicity studies have been conducted with epcoritamab-bysp. epcoritamab-bysp causes t-cell activation and cytokine release; immune activation may compromise pregnancy maint

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - interferon gamma-1b, quantity: 4 million iu/ml - injection, solution - excipient ingredients: succinic acid; sodium succinate hexahydrate; mannitol; water for injections; polysorbate 20 - as an adjunct for reduction of the frequency of serious infections in patients with chronic granulomatous disease (cgd). the benefits of imukin have been most marked in children with cgd although imukin may be used in adult patients.

以色列 - 英文 - Ministry of Health

medison pharma ltd - zanubrutinib - capsules - zanubrutinib 80 mg - • brukinsa is indicated for the treatment of adult patients with mantle cell lymphoma (mcl) who have received at least one prior therapy.• brukinsa is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm).• brukinsa is indicated for the treatment of adult patients with relapsed or refractory marginal zone lymphoma (mzl) who have received at least one anti-cd20-based regimen.• brukinsa is indicated for the treatment of adult patients with chronic lymphocytic leukemia (cll) or small lymphocytic lymphoma (sll).

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

victorian institute of forensic medicine t/a donor tissue bank of victoria - skin, quantity: 24 cm2 - graft - excipient ingredients: - skin - treatment of dermatological disorder/disease/trauma

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

metro south hospital and health service t/a queensland tissue bank - skin, quantity: 1 u - graft - excipient ingredients: glycerol; glucose monohydrate; ascorbic acid; polysorbate 80; sodium chloride; dibasic sodium phosphate; guanine hydrochloride monohydrate; monobasic potassium phosphate; dried magnesium sulfate; aminobenzoic acid; adenine sulfate dihydrate; alanine; arginine hydrochloride; aspartic acid; biotin; cholesterol; calcium chloride dihydrate; cysteine hydrochloride monohydrate; cystine; choline chloride; calcium pantothenate; deoxyribose; ergocalciferol; ferric nitrate nonahydrate; folic acid; glycine; glutamic acid; glutathione; histidine hydrochloride monohydrate; hydroxyproline; sodium hypoxanthine; isoleucine; inositol; leucine; betaine; methionine; menadione; nicotinic acid; nicotinamide; phenolsulfonphthalein; potassium chloride; pyridoxal hydrochloride; pyridoxine hydrochloride; phenylalanine; proline; retinol acetate; riboflavin; ribose; serine; sodium acetate; sodium bicarbonate; thymine; tyrosine disodium; thiamine hydrochloride; dl-alpha-tocopheryl phosphate disodium; threonine; tryptophan; uracil; valine; sodium xanthine; adenosine phosphate; adenosine triphosphate disodium trihydrate - skin - restoration/repair of dermatological function

以色列 - 英文 - Ministry of Health

neopharm ltd, israel - lonafarnib - hard gelatin capsules - lonafarnib 50 mg - lonafarnib - zokinvy is indicated in patients 12 months of age and older with a body surface area (bsa) of0.39 m2 and above:to reduce the risk of mortality in hutchinson-gilford progeria syndrome (hgps)• for the treatment of processing-deficient progeroid laminopathies with either:o heterozygous lmna mutation with progerin-like protein accumulationo homozygous or compound heterozygous zmpste24 mutationslimitations of usezokinvy is not indicated for other progeroid syndromes or processing-proficient progeroid laminopathies. based upon its mechanism of action, zokinvy would not be expected to be effective in these populations.

以色列 - 英文 - Ministry of Health

neopharm ltd, israel - lonafarnib - hard gelatin capsules - lonafarnib 75 mg - lonafarnib - zokinvy is indicated in patients 12 months of age and older with a body surface area (bsa) of0.39 m2 and above:to reduce the risk of mortality in hutchinson-gilford progeria syndrome (hgps)• for the treatment of processing-deficient progeroid laminopathies with either:o heterozygous lmna mutation with progerin-like protein accumulationo homozygous or compound heterozygous zmpste24 mutationslimitations of usezokinvy is not indicated for other progeroid syndromes or processing-proficient progeroid laminopathies. based upon its mechanism of action, zokinvy would not be expected to be effective in these populations.

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

moogoo skin care pty ltd - 58418 - skin detoxifier - a non-sterile, locally-administered powder compound intended to absorb and remove potentially detrimental (harmful) substances from the skin surface including atypical sebaceous exudates and the allergenic and inflammatory substances associated with demodex mite infestation and rosacea. the absorbent may also act as a physical, desiccant acaricide. after application, the device cannot be reused.

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

moogoo skin care pty ltd - 46206 - skin moisturizing/barrier dressing - the indented purpose of the device is dermal application to essentially healthy, unbroken skin for prophylaxis of radiation dermatitis. the cream is applied following radiation therapy to alleviate dry, irritated and flaky skin.

美国 - 英文 - NLM (National Library of Medicine)

skin sake, llc - dimethicone (unii: 92ru3n3y1o) (dimethicone - unii:92ru3n3y1o) - dimethicone 2.272 g in 113.6 g - skin protectant - helps soothe, treat, and prevent ulcer-prone areas, cracked skin, rashes - repels wetness - protects delicate skin - relieves chapped, moist areas - prevents friction